Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.
It has recently revealed a preliminary agreement to place its VaMousse head lice product with a major US pharmacy chain in 2014.
Discussions with other pharmacy chains are reportedly ongoing. Agreements with these additional chains could lead to penetration of almost a third of the US pharmacy market.